微波辐射下合成2-甲硫基-3-氰基-7-取代苯基吡唑并[1,5-a]嘧啶及生物活性的研究

利用取代烯胺酮1与3-甲硫基-4-氰基-5-氨基-1H-吡唑(2)反应,用传统和微波2种方法合成了6种化合物2-甲硫基-3-氰基-7-取代苯基吡唑并[1,5-a]嘧啶(3a～3f),化合物的结构均经元素分析,IR,1H NMR所证实.对比两种方法,微波辐射具有用时少、环境友好、易纯化和产率高的特点,同时,探讨了反应可能的机理,并对所有化合物的杀菌和除草活性进行了测试.     

1-芳胺羰基-3-苄硫基-4-乙氧羰基(或氰基)-5-氨基吡唑的合成及生物活性

利用5-氨基-4-乙氧羰基(或氰基)-3-苄硫基吡唑与异氰酸酯的加成反应合成了一系列1-芳胺羰基-3-苄硫基-4-乙氧羰基(或氰基)-5-氨基吡唑。利用分子力学计算,解释了¹HNMR谱中的取代基效应。生物活性测定结果表明部分化合物具有良好的除草活性。     

基于Strecker反应的含氰基多取代吡唑的合成及生物活性研究

为探索多取代吡唑胺的Strecker反应及含氰基吡唑化合物的生物活性,首次实现了ZnI2催化下多取代吡唑胺、三甲基硅腈(TMSCN)和醛的Strecker反应,初步探索了反应条件及醛底物的范围.共获得20个全新含氰基多取代吡唑目标物,最高收率为93.5%,并通过核磁共振氢谱(~1H NMR)、碳谱(~(13)C NMR)和高分辨质谱(HRMS)确证了其结构.活性测试表明, 10×10~(-3)g/L浓度下,13个化合物对蚊幼虫活性为100%,5×10~(-3)g/L浓度下4个化合物活性高于40%;在500×10~(-3) g/L浓度下10个化合物对黏虫体现一定活性.在500×10~(-3) g/L浓度下5个化合物对烟草花叶病毒具有一定钝化活性,最高活性为31.8%, 4个化合物则具有保护活性,最高活性为28.3%.在50×10~(-3) mg/mL浓度下, 3个化合物对瓜果腐霉菌、芦笋茎枯菌、辣椒疫霉菌、水稻纹枯菌等显示一定抑制活性,其中4-[(1-氰基十二烷基)氨基]-5-乙基-N-甲基-1H-吡唑-3-甲酰胺(3t)对辣椒疫霉活性达62.3%.这表明氨基邻位具有大位阻基团的吡唑胺底物能顺利发生Strecker反应,含氰基吡唑类目标物显示多样的生物活性,具有一定的研究价值.     

3-(2-氟-4-氯-5-取代基苯基)-7-甲基-H3-吡唑并[3,4-d][1,2,3]三嗪-4(7H)-酮化合物的合成及其对原卟啉原氧化酶的抑制活性

为了发现新型的原卟啉原氧化酶抑制剂,根据生物合理设计方法,设计并合成了一系列的结构新颖的3H-吡唑并[3,4-d][1,2,3]三嗪-4-酮衍生物.利用不同取代的5-氨基-吡唑-4-甲酰氯与取代苯胺反应制得的5-氨基-N-苯基-1H-吡唑-4-甲酰胺衍生物,经进一步重氮化得到目标化合物,并对化合物3f进行衍生化.所得目标化合物的结构均经1HNMR,IR和元素分析确证.生物活性测定结果表明,部分化合物对原卟啉原氧化酶有较高的抑制活性,讨论了其结构与活性的关系.     

3-(2-氟-4-氯-5-取代基苯基)-7-甲基-3H-吡唑并[3,4-d][1,2,3]三嗪- 4(7H)-酮化合物的合成及其对原卟啉原氧化酶的抑制活性

为了发现新型的原卟啉原氧化酶抑制剂, 根据生物合理设计方法, 设计并合成了一系列的结构新颖的3H-吡唑并[3,4-d][1,2,3]三嗪-4-酮衍生物. 利用不同取代的5-氨基-吡唑-4-甲酰氯与取代苯胺反应制得的5-氨基-N-苯基-1H-吡 唑-4-甲酰胺衍生物, 经进一步重氮化得到目标化合物, 并对化合物3f进行衍生化. 所得目标化合物的结构均经1H NMR, IR和元素分析确证. 生物活性测定结果表明, 部分化合物对原卟啉原氧化酶有较高的抑制活性, 讨论了其结构与活性的关系.     

新型吡唑甲酰胺类化合物的合成及其抗肿瘤活性

以2-氰基乙酰胺为起始原料,与三乙氧基取代化合物经加成反应制得取代烯酰胺类化合物(3a~3c);3a~3c与芳肼经环合反应得取代吡唑-4-甲酰胺类化合物(5a~5d);5a~5d与酰氯经酰化反应合成了6个新型的1-芳基-3-取代-5-取代氨基-4-吡唑甲酰胺类化合物(7a~7f),其结构经1H NMR,MS和元素分析表征。抗肿瘤活性测试结果表明,7a~7f对人乳腺癌细胞(A)、人宫颈癌细胞(B)和人肝癌细胞(C)有一定抑制作用,其中3-甲基-5-[4-(甲磺酰胺基)苯甲酰胺]-1-苯基-1H-吡唑-4-甲酰胺(7f)的抑制活性最好,对A,B和C的IC50分别为3.25μM,8.74μM和10.47μM。     

水中3-甲基-6-氨基-5-氰基-4-芳基-1-苯基-1，4-二氢吡喃[2，3-c]吡唑的洁净合成

在水溶剂中并有三乙基苄基氯化铵（TEBA）存在下，取代芳亚甲基丙二腈与3- 甲基-1-苯基-2-吡唑啉-5-酮缩合成为3-甲基-6-氨基-5-氰基-4-芳基-1-苯基-1， 4-二氢吡喃[2,3-c]吡唑，此法为相应化合物的合成提供了一种快速、方便、高效 和洁净的方法。     

取代吡唑啉衍生物的合成与生物活性

采用α-三唑-β-烷氧基芳酮与肼关环,制备了1,3-二苯基-4-三唑基吡唑啉1a,1-苯基-3-对氯苯基-4-三唑基吡唑啉1b和3-取代苯基-4-三唑基吡唑啉(7),并研究了化合物7的成环优化条件.使用α,β-不饱和酮与肼关环合成了1,3,4,5-多取代吡唑啉衍生物1c-1h,并初步用质谱法确定了该反应产物的结构;同时,以3,5-二取代吡唑啉(6)和7作为中间体合成了1-,3-,4-或5-取代的化合物2a-2l.初步生物活性测定结果表明,所合成的化合物均有一定的杀菌、激素和除草效果.     

含1,3,4-噻二唑环吡唑并[3,4-d]嘧啶类化合物的合成及生物活性

通过5-氨基-4-氰基-1-苯基吡唑与甲酸发生环合、再经氯化和芳香族亲核取代反应,合成了12种新的含1,3,4-噻二唑环吡唑并[3,4-d]嘧啶类化合物.目标化合物的结构经红外光谱、核磁共振氢谱、质谱和元素分析方法予以确认.初步的生物活性测定试验表明,在50 mg/L浓度下,大部分目标化合物对小麦纹枯病菌(Rhizoctonia cerealis)表现出较好的杀菌活性,其中化合物5b,5d和5j的抑菌率超过90%.     

超声波辐射下合成N-取代苯并噻唑-2-氨基-N'-取代吡唑-4-甲酰基硫脲

为实现多种活性成分的有效叠加和为药物筛选提供先导化合物,以1-苯基-3-甲基-5-氯/苯氧基-4-吡唑甲酸为初始原料,依次合成1-苯基-3-甲基-5-氯/苯氧基-4-吡唑甲酰氯、1-苯基-3-甲基-5-氯/苯氧基-4-吡唑甲酰基异硫氰酸酯,再与取代苯并噻唑肼反应生成了8个未见报道的N-取代苯并噻唑-2-氨基-N'-取代吡唑-4-甲酰基硫脲.采用超声波催化法合成了标题化合物,并与加热回流的常规方法进行了对比.超声波催化法具有操作简单、反应时间短、条件温和、产率高、副反应少等优点,为此类化合物的合成提供了一种有效的新方法.标题化合物经元素分析,IR,1HNMR确证结构.     

4‐Aryl‐2‐ferrocenyl‐ and 2‐Aryl‐4‐ferrocenyl‐2,3‐dihydro‐1,5‐benzothiazepines with Potentially Biological Activities: Synthesis,Characterization, X‐ray Diffraction Studies

A series of novel 4‐aryl‐2‐ferrocenyl‐ and 2‐aryl‐4‐ferrocenyl‐2,3‐dihydro‐1,5‐benzothiazepines 3a , 3b , 3c , 3d , 3e , 3f and 6a , 6b , 6c , 6d , 6e was obtained by the condensation of 1‐aryl‐3‐ferrocenyl‐ and 3‐aryl‐1‐ferrocenyl‐2‐propenones 1a , 1b , 1c , 1d , 1e , 1f and 4a , 4b , 4c , 4d , 4e , respectively, with o‐aminothiophenol in the presence of AcOH and HCl (~64–91%). Their structures were established based on the spectroscopic data and X‐ray diffraction analysis of the compounds 3d , 5a , and 6c .     

An efficient synthesis of 5‐aryl‐4,5‐dihydro‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐(4‐phenylthiazol‐2‐yl)pyrazoles

Some new target products 5‐aryl‐4,5‐dihydro‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐1‐(4‐phenylthiazol‐2‐yl)pyrazoles 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j have been synthesized by reaction of 2‐bromo‐1‐phenylethanone and compounds 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j which were prepared from the combination of thiosemicarbazide and (E)‐3‐aryl‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐prop‐2‐en‐1‐ones 3a , 3b , 3c , 3d , 3e , 3f , 3g , 3h , 3i , 3j . All the structures were established by MS, IR, CHN, and ¹H NMR spectra data. Synthesis of structure diversity is applied. J. Heterocyclic Chem., (2011).     

New N‐(Aryl)‐5‐((quinolin‐8‐yloxy)methyl)‐1,3,4‐oxa/Thiadiazol‐2‐amines and 4‐Aryl‐5‐((quinolin‐8‐yloxy)methyl)‐2H‐1,2,4‐triazole‐3(4H)‐thiones,Synthesis and Characterization

In this study, methyl 2‐(quinolin‐8‐yloxy) acetate ( 2 ) obtained by reaction of 8‐hydroxyquinoline ( 1 ) with methyl chloroacetate was condensed with hydrazine hydrate to afford the carbohydrazide ( 3 ). Thio/semicarbazide derivatives ( 4a , 4b , 4c , 4d , 4e , 4f , 4g ) were obtained by treatment of the 3 with substituted phenyl iso/thioisocyanates. The 4a , 4b , 4c , 4d , 4e , 4f , 4g on acidic and basic intramolecular cyclization led to N‐(aryl)‐5‐((quinolin‐8‐yloxy)methyl)‐1,3,4‐oxa/thiadiazol‐2‐amines ( 5a , 5b , 5c , 5d , 5e , 5f , 5g ) and 4‐aryl‐5‐((quinolin‐8‐yloxy)methyl)‐2H‐1,2,4‐triazole‐3(4H)‐thiones ( 6a , 6b , 6c , 6d , 6e , 6f , 6g ), respectively. All the synthesized compounds were characterized by spectroscopic techniques and elemental analyses. The thiosemicarbazide ( 4c ) was also confirmed by X‐ray crystallography.     

Synthesis of 2‐(sulfamoylphenyl)‐4′‐(iminoaryl/hetroaryl)‐4‐(4′′‐hydroxyphenyl)‐thiazoles and their O‐glucosides

In continuation of our work, we synthesized 2‐(sulfamoylphenyl)‐4′‐amino‐4‐(4″‐hydroxyphenyl)‐thiazole ( 3a ), which were reacted with various (aryl/hetroaryl) aldehyde to form 2‐(sulfamoylphenyl)‐4′‐(iminoaryl/hetroaryl)‐4‐(4″‐hydroxyphenyl)‐thiazoles ( 4a , 4b , 4c , 4d , 4e , 4f ). Glucosylation of compounds ( 4a , 4b , 4c , 4d , 4e , 4f ) have been done by using acetobromoglucose as a glucosyl donor to afford 2‐(sulfamoylphenyl)‐4′‐(iminoaryl/hetroaryl)‐4‐(2,3,4,6‐tetra‐O‐acetyl‐4″‐O‐β‐D ‐glucosidoxyphenyl)‐thiazoles ( 5a , 5b , 5c , 5d , 5e , 5f ), further on deacetylation to produce 2‐(sulfamoylphenyl)‐4′‐(iminoaryl/hetroaryl)‐4‐(4″‐O‐β‐D ‐glucosidoxyphenyl)‐thiazoles ( 6a , 6b , 6c , 6d , 6e , 6f ). The compounds are confirmed by FTIR, ¹H‐NMR, ¹³C‐NMR, and ES‐Mass spectral analysis. J. Heterocyclic Chem., (2011).     

A facile synthesis of 2‐substituted thieno[3′,2′‐5,6]‐pyrido[4,3‐d]pyrimidin‐4(3H)‐ones

The thienopyridine derivative 2 , obtained from reaction of acetoacetic ester with 1 in the presence of tin tetrachloride, was treated with triphenylphosphine in hexachloroethane and Et₃N to give iminophosphorane 3 . Iminophosphorane 3 reacted with phenyl isocyanate to give carbodiimide 4 , which was further treated with phenols or ethenol to produce 2‐substituted 5,8,9‐trimethyl‐3‐phenyl‐thieno[3′,2′‐5,6]pyrido[4,3‐d]pyrimidin‐4(3H)‐ones 5 in presence of catalytic amount of K₂CO₃ or EtONa. The structures of compounds 5 were confirmed by ¹H NMR, IR, MS, and elemental analysis.     

Synthesis and antimicrobial activities of new 4,6‐diaryl‐ 4,5‐dihydro‐3‐hydroxy‐2H‐indazoles

A series of new 4,6‐diaryl‐4,5‐dihydro‐3‐hydroxy‐2H‐indazoles 5a , 5b , 5c , 5d , 5e , 5f , 5g , 5h , 5i , 5j , 5k were synthesized by the cyclization of ethyl 2‐oxo‐4,6‐diarylcyclohex‐3‐ene carboxylates 4a , 4b , 4c , 4d , 4e , 4f , 4g , 4h , 4i , 4j , 4k . The compounds were characterized by IR, ¹H NMR, ¹³C NMR, 2D NMR, and elemental analysis. The synthesized compounds were evaluated for in vitro antibacterial and antifungal activities against Staphylococcus aureus, Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger, Aspergillus flavus, and Rhizopus sp. Most of the compounds exhibited good activity against the tested organisms. J. Heterocyclic Chem.,, (2012).     

A simple synthesis of 5‐ethoxycarbonyl‐6‐phenyl‐1,3‐dioxin‐4‐ones and ethyl 3‐benzoyl‐4‐oxo‐2,6‐diphenylpyran‐5‐carboxylate

4‐Ethoxycarbonyl‐5‐phenyl‐2,3‐dihydrofuran‐2,3‐dione 1 reacts with aldehydes via the acylketene intermediate 2 giving the 1,3‐dioxin‐4‐ones 3a‐e and the 1,4‐bis(5‐ethoxycarbonyl‐4‐oxo‐6‐phenyl‐4H‐1,3‐dioxin‐2‐yl)benzene 4 , and a one step reaction between dibenzoylmethane and oxalylchloride gave 3,5‐dibenzoyl‐2,6‐diphenyl‐4‐pyrone 7 . The reaction of 1 with dibenzoylmethane, a dicarbonyl compound, provided ethyl 3‐benzoyl‐4‐oxo‐2,6‐diphenylpyran‐5‐carboxylate derivative 9 . Compound 9 was converted into the corresponding ethyl 3‐benzoyl‐4‐hydroxy‐2,6‐diphenylpyridine‐5‐carboxylate derivative 10 via its reaction with ammonium hydroxyde solution in 1 ‐butanol.     

Synthesis and characterization of a series of 1,x‐bis‐(4‐oxo‐3,4‐dihydro‐1,2,3‐benzotriazin‐3‐yl)alkanes

Reaction of isatoic anhydride with an alkanediamine in DMF solution under mild conditions affords excellent yields of the 1,x‐bis‐{(2‐aminobenzoyl‐)amino}alkanes ( 2a‐k ), which have been characterized by IR and NMR spectroscopy, high resolution mass spectrometry and elemental analysis. Diazotization of the bis‐{(2‐aminobenzoyl‐)‐amino}alkanes in aqueous solution gives high yields of the 1,x‐bis‐(4‐oxo‐3,4‐dihydro‐1,2,3‐benzotriazin‐3‐yl)alkanes ( 1a‐k ), whch have also been characterized by IR and NMR spectroscopy, high resolution mass spectrometry and elemental analysis. The alkanediamines employed are as follows: ethylene diamine, 1,3‐propanediamine, 1,2‐propanediamine, 2‐methyl‐1,2‐propanediamine, 2,2‐dimethyl‐1,3‐propanediamine, 2‐hydroxy‐1,3‐propanediamine, 1,4‐diaminobutane, 1,5‐diaminopentane, 1,3‐diaminopentane (DYTEK® EP diamine), 1,6‐diaminohexane and 1,7‐diaminoheptane. The alternative method of synthesis of the bis‐(4‐oxo‐3,4‐dihydro‐1,2,3‐benzotriazin‐3‐yl)alkanes ( 1 ) via the diazonium salt from methyl anthranilate was explored.     

Quinolone Analogs 14: Synthesis of Antimalarial 1‐Aryl‐3‐(4‐quinolon‐2‐yl)ureas and Related Compounds

The 4‐quinolone‐2‐carbohydrazide 6a was converted into 1‐aryl‐3‐(4‐quinolon‐2‐yl)ureas 5a , 5b , 5c , 5d , 5e , 1‐aryl‐3‐(4‐quinolon‐2‐yl)imidazolidine‐2,4‐diones 9a , 9b , and N‐(4‐quinolon‐2‐yl)carbamates 10a , 10b via 4‐quinolone‐2‐carbonylazide 7a . The 4‐methoxyquinoline‐2‐carbohydrazide 6b was also transformed into 1‐aryl‐3‐(4‐methoxyquinolin‐2‐yl)ureas 11a , 11b , 11c , 11d , 1‐aryl‐3‐(4‐methoxyquinolin‐2‐yl)imidazolidine‐2,4‐diones 12a , 12b , and N‐(4‐methoxyquinolin‐2‐yl)carbamates 13a , 13b via 4‐methoxyquinoline‐2‐carbonylazide 7b . Some of the 1‐aryl‐3‐(4‐quinolon‐2‐yl)ureas 5a , 5b , 5c , 5d , 5e showed the in vitro antimalarial activity to chloroquine‐resistant Plasmodium falciparum, wherein IC₅₀ was 0.93 to 4.00 μM.     

Simple and Efficient Synthesis of Novel 3‐Substituted 2‐Thioxo‐2,3‐dihydro‐1H‐benzo[g]quinazolin‐4‐ones and Their Reactions with Alkyl Halides and α‐Glycopyranosyl Bromides

A series of 3‐substituted 2‐thioxo‐2,3‐dihydro‐1H‐benzo[g]quinazolin‐4‐ones 4a – e were synthesized from the reaction of 3‐aminonaphthalene‐2‐carboxylic acid 1 with isothiocyanate derivatives 2a – e . The alkylation of 4a – e with alkyl halides gave 3‐substituted 2‐alkylsulfanyl‐2,3‐dihydro‐1H‐benzo[g]quinazolin‐4‐ones 5a – o . S‐Glycosylation was carried out via the reaction of 4a – e with glycopyranosyl bromides 7a and 7b under anhydrous alkaline conditions. The structure of the compounds was established as S‐nucleoside and not N‐nucleoside. Conformational analysis has been studied by homonuclear and heteronuclear two‐dimensional NMR methods (2D DFQ‐COSY, heteronuclear multiple quantum coherence, and heteronuclear multiple bond correlation). The S site of alkylation and glycosylation was determined from the ¹H and ¹³C heteronuclear multiple quantum coherence experiments.